291 items found
Abi-Dargham A;Rodenhiser J;Printz D;Zea-Ponce Y;Gil R;Kegeles LS;Weiss R;Cooper TB;Mann JJ;Van Heertum RL;Gorman JM;Laruelle M;
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America.
2000;97(14):8104-8109
Alexopoulos GS;Kiosses DN;Choi SJ;Murphy CF;Lim KO;
Frontal white matter microstructure and treatment response of late-life depression: a preliminary study.
American Journal of Psychiatry.
2002;159(11):1929-1932
Andorfer C;Acker CM;Kress Y;Hof PR;Duff K;Davies P;
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.
Journal of Neuroscience.
2005;25(22):5446-5454
Arancio O;Antonova I;Gambaryan S;Lohmann SM;Wood JS;Lawrence DS;Hawkins RD;
Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation.
Journal of Neuroscience.
2001;21(1):143-149
Arancio O;Zhang HP;Chen X;Lin C;Trinchese F;Puzzo D;Liu S;Hegde A;Yan SF;Stern A;Luddy JS;Lue LF;Walker DG;Roher A;Buttini M;Mucke L;Li W;Schmidt AM;Kindy M;Hyslop PA;Stern DM;Du Yan SS;
RAGE potentiates Abeta-induced perturbation of neuronal function in transgenic mice.
EMBO Journal.
2004;23(20):4096-4105
Ardekani BA;Bappal A;D'angelo D;Ashtari M;Lencz T;Szeszko PR;Butler PD;Javitt DC;Lim KO;Hrabe J;Nierenberg J;Branch CA;Hoptman MJ;
Brain morphometry using diffusion-weighted magnetic resonance imaging: application to schizophrenia.
Neuroreport.
2005;16(13):1455-1459
Ardekani BA;Guckemus S;Bachman A;Hoptman MJ;Wojtaszek M;Nierenberg J;
Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans.
Journal of Neuroscience Methods.
2005;142(1):67-76
Bai Y;Markham K;Chen F;Weerasekera R;Watts J;Horne P;Wakutani Y;Mathews PM;Fraser PE;Westaway D;St George-Hyslop P;Schmitt-Ulms G;
The in vivo brain interactome of the amyloid precursor protein.
Molecular & Cellular Proteomics.
2008;7(1):15-34
Bartlett EJ;Brodie JD;Simkowitz P;Schlosser R;Dewey SL;Lindenmayer JP;Rusinek H;Wolkin A;Cancro R;Schiffer W;
Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.
American Journal of Psychiatry.
1998;155(3):337-343
Bartus RT;Emerich D;Snodgrass-Belt P;Fu K;Salzberg-Brenhouse H;Lafreniere D;Novak L;Lo ES;Cooper T;Basile AS;
A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.
Journal of Pharmacology & Experimental Therapeutics.
2004;310(2):828-835
Basavarajappa BS;
Critical enzymes involved in endocannabinoid metabolism.
Protein & Peptide Letters.
2007;14(3):237-246
Basavarajappa BS;
Neuropharmacology of the endocannabinoid signaling system: molecular mechanisms, biological actions and synaptic plasticity.
Current Neuropharmacology.
2007;5(2):81-97
Basavarajappa BS;
The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.
Mini-Reviews in Medicinal Chemistry.
2007;7(8):769-779
Basavarajappa BS;Hungund BL;
Role of the endocannabinoid system in the development of tolerance to alcohol.
Alcohol and Alcoholism.
2005;40(1):15-24
Bilder RM;
Neurocognitive impairment in schizophrenia and how it affects treatment options. [Review].
Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.
1997;42(3):255-264
Bilder RM;Goldman RS;Robinson D;Reiter G;Bell L;Bates JA;Pappadopulos E;Willson DF;Alvir JMJ;Woerner MG;Geisler S;Kane JM;Lieberman JA;
Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates.
American Journal of Psychiatry.
2000;157(4):549-559
Bilder RM;Goldman RS;Volavka J;Czobor P;Hoptman M;Sheitman B;Lindenmayer JP;Citrome L;McEvoy J;Kunz M;Chakos M;Cooper TB;Horowitz TL;Lieberman JA;
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder [Comment in: Am J Psychiatry. 2002 Dec;159(12):2118; author reply 2118-9].
American Journal of Psychiatry.
2002;159(6):1018-1028
Bonanomi D;Menegon A;Miccio A;Ferrari G;Corradi A;Kao HT;Benfenati F;Valtorta F;
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons.
Journal of Neuroscience.
2005;25(32):7299-7308
Boroojerdi B;Bushara KO;Corwell B;Immisch I;Battaglia F;Muellbacher W;Cohen LG;
Enhanced excitability of the human visual cortex induced by short-term light deprivation.
Cerebral Cortex.
2000;10(5):529-534
Bourgeois M;Swendsen J;Young F;Amador X;Pini S;Cassano GB;Lindenmayer JP;Hsu C;Alphs L;Meltzer HY;The InterSePT Study Group;
Awareness of disorder and suicide risk in the treatment of schizophrenia: results of the international suicide prevention trial.
American Journal of Psychiatry.
2004;161(8):1494-1496
Burns M;Gaynor K;Olm V;Mercken M;LaFrancois J;Wang L;Mathews PM;Noble W;Matsuoka Y;Duff K;
Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo.
Journal of Neuroscience.
2003;23(13):5645-5649
Butler PD;Hoptman MJ;Nierenberg J;Foxe JJ;Javitt DC;Lim KO;
Visual white matter integrity in schizophrenia.
American Journal of Psychiatry.
2006;163(11):2011-2013
Butler PD;Javitt DC;
Early-stage visual processing deficits in schizophrenia.
Current Opinion in Psychiatry.
2005;18(2):151-157
Butler PD;Schechter I;Zemon V;Schwartz SG;Greenstein VC;Gordon J;Schroeder CE;Javitt DC;
Dysfunction of early-stage visual processing in schizophrenia [Comment in: Am J Psychiatry. 2002 Apr;159(4):678; author reply 678-9].
American Journal of Psychiatry.
2001;158(7):1126-1133
Butler PD;Zemon V;Schechter I;Saperstein AM;Hoptman MJ;Lim KO;Revheim N;Silipo G;Javitt DC;
Early-stage visual processing and cortical amplification deficits in schizophrenia.
Archives of General Psychiatry.
2005;62(5):495-504
Calingasan NY;Park LC;Calo LL;Trifiletti RR;Gandy SE;Gibson GE;
Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.
American Journal of Pathology.
1998;153(2):599-610
Cancro R;
Book review: The Prehistory of the Mind: The Cognitive Origins of Art, Religion and Science.
American Journal of Psychiatry.
1998;155(12):1797
Cancro R;
Book review: Delayed Posttraumatic Stress Disorders From Infancy: The Two Trauma Mechanism.
American Journal of Psychiatry.
1998;155(5):701-702
Cancro R;
Book review: Neurology for Non-Neurologists, 3rd ed..
American Journal of Psychiatry.
1998;155(4):569-570
Cancro R;
Book review: Cambridge Handbook of Psychology, Health and Medicine.
American Journal of Psychiatry.
1999;156(7):1112
Cancro R;
The introduction of neuroleptics: A psychiatric revolution.
Psychiatric Services.
2000;51(3):333-335
Cancro R;
Book review: Psychiatric Drugs.
American Journal of Psychiatry.
2001;158(2):331
Cancro R;
Book review: Recognition and Treatment of Psychiatric Disorders: A Psychopharmacology Handbook for Primary Care.
American Journal of Psychiatry.
2001;158(2):331
Cancro R;
Book review: Drug Effects on Psychomotor Performance.
American Journal of Psychiatry.
2002;159(1):168
Cancro R;
Book review: Ethics, Culture, and Psychiatry: International Perspectives.
American Journal of Psychiatry.
2003;160(9):1712
Cancro R;
Book review: The Difficult-to-Treat Psychiatric Patient.
American Journal of Psychiatry.
2003;160(1):201
Capell A;Grunberg J;Pesold B;Diehlmann A;Citron M;Nixon R;Beyreuther K;Selkoe DJ;Haass C;
The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex.
Journal of Biological Chemistry.
1998;273(6):3205-3211
Cataldo AM;Barnett JL;Pieroni C;Nixon RA;
Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.
Journal of Neuroscience.
1997;17(16):6142-6151
Cataldo AM;Petanceska S;Peterhoff CM;Terio NB;Epstein CJ;Villar A;Carlson EJ;Staufenbiel M;Nixon RA;
App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
Journal of Neuroscience.
2003;23(17):6788-6792
Cataldo AM;Peterhoff CM;Troncosco JC;GomezIsla T;Hyman BT;Nixon RA;
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome - Differential effects of APOE genotype and presenilin mutations.
American Journal of Pathology.
2000;157(1):277-286
Che S;Ginsberg SD;
Amplification of RNA transcripts using terminal continuation.
Laboratory Investigation.
2004;84(1):131-137
Chen F;Yang DS;Petanceska S;Yang A;Tandon A;Yu G;Rozmahel R;Ghiso J;Nishimura M;Zhang DM;Kawarai T;Levesque G;Mills J;Levesque L;Song YQ;Rogaeva E;Westaway D;Mount H;Gandy S;George-Hyslop P;Fraser PE;
Carboxyl-terminal fragments of Alzheimer beta -amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells.
Journal of Biological Chemistry.
2000;275(47):36794-36802
Chen PX;Mathews PM;Good PJ;Rossier BC;Geering K;
Unusual degradation of alpha-beta complexes in Xenopus oocytes by beta-subunits of Xenopus gastric H-K-ATPase.
American Journal of Physiology.
1998;275(1 Pt 1):C139-C145
Cheney DL;Uzunov D;Costa E;Guidotti A;
Gas chromatographic-mass fragmentographic quantitation of 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats.
Journal of Neuroscience.
1995;15(6):4641-4650
Chishti MA;Yang DS;Janus C;Phinney AL;Horne P;Pearson J;Strome R;Zuker N;Loukides J;French J;Turner S;Lozza G;Grilli M;Kunicki S;Morissette C;Paquette J;Gervais F;Bergeron C;Fraser PE;Carlson GA;George-Hyslop PS;Westaway D;
Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.
Journal of Biological Chemistry.
2001;276(24):21562-21570
Choi IY;Gruetter R;
Dynamic or inert metabolism? Turnover of N-acetyl aspartate and glutathione from d-[1-C]glucose in the rat brain in vivo.
Journal of Neurochemistry.
2004;91(4):778-787
Choi SI;Vidal R;Frangione B;Levy E;
Axonal transport of British and Danish amyloid peptides via secretory vesicles.
FASEB Journal.
2004;18(2):373-375
Chou JC;
Review and update of the American Psychiatric Association practice guideline for bipolar disorder.
Primary Psychiatry.
2004;11(9):73-84
Christensen BK;Bilder RM;
Dual cytoarchitectonic trends: an evolutionary model of frontal lobe functioning and its application to psychopathology.
Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.
2000;45(3):247-256
Citrome L;
Schizophrenia and valproate.
Psychopharmacology Bulletin.
2003;37(Suppl 2):74-88
Citrome L;
Re: Treatment noncompliance with orally disintegrating olanzapine tablets.
Canadian Journal of Psychiatry - Revue Canadienne de Psychiatrie.
2004;49(6):412-413
Citrome L;
Antihostility effects of adjunctive divalproex [letter].
Psychiatric Services.
2004;55(9):1068-1069
Citrome L;Casey DE;Daniel DG;Wozniak P;Kochan LD;Tracy KA;
Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone.
Psychiatric Services.
2004;55(3):290-294
Citrome L;Jaffe A;Levine J;Allingham B;
Use of mood stabilizers among patients with schizophrenia, 1994-2001.
Psychiatric Services.
2002;53(10):1212
Citrome L;Jaffe A;Levine J;Allingham B;Robinson J;
Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Psychiatric Services.
2004;55(9):1006-1013
Citrome L;Levine J;Allingham B;
Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998.
Psychiatric Services.
2000;51(5):634-638
Citrome L;Volavka J;
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes: Response to consensus statement.
Diabetes Care.
2004;27(8):2087-2088
Citrome L;Volavka J;Czobor P;Sheitman B;Lindenmayer JP;McEvoy J;Cooper TB;Chakos M;Lieberman JA;
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
Psychiatric Services.
2001;52(11):1510-1514
Citrome LL;
Efficacy should drive atypical antipsychotic treatment [letter].
BMJ.
2003;326(7383):283
Coccaro EF;Kavoussi RJ;Cooper TB;Hauger RL;
Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects.
American Journal of Psychiatry.
1997;154(10):1430-1435
Coccaro EF;Kavoussi RJ;Hauger RL;Cooper TB;Ferris CF;
Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects.
Archives of General Psychiatry.
1998;55(8):708-714
Convit A;de Leon MJ;Tarshish C;De Santi S;Wells C;George A;Saint Louis LA;Rusinek H;
Hippocampal atrophy as detected by width of the temporal horn is greater in Alzheimer dementia than in nondementing cognitive impairment [comment].
American Journal of Neuroradiology.
1997;18(6):1193-1195
Convit A;Wolf OT;Tarshish C;de Leon MJ;
Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.
Proceedings of the National Academy of Sciences of the United States of America.
2003;100(4):2019-2022
Coplan JD;Trost RC;Owens MJ;Cooper TB;Gorman JM;Nemeroff CB;Rosenblum LA;
Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions.
Archives of General Psychiatry.
1998;55(5):473-477
Counts SE;Perez SE;Ginsberg SD;De Lacalle S;Mufson EJ;
Galanin in Alzheimer disease.
Molecular Interventions.
2003;3(3):137-156
de Leon MJ;Convit A;Wolf OT;Tarshish CY;DeSanti S;Rusinek H;Tsui W;Kandil E;Scherer AJ;Roche A;Imossi A;Thorn E;Bobinski M;Caraos C;Lesbre P;Schlyer D;Poirier J;Reisberg B;Fowler J;
Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/poitron-emission tomography (FDG/PET).
Proceedings of the National Academy of Sciences of the United States of America.
2001;98(19):10966-10971
de Leon MJ;McRae T;Rusinek H;Convit A;De Santi S;Tarshish C;Golomb J;Volkow N;Daisley K;Orentreich N;McEwen B;
Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease.
Journal of Clinical Endocrinology & Metabolism.
1997;82(10):3251-3259
DeLisi LE;
Dr. DeLisi replies.
American Journal of Psychiatry.
2004;161(8):1508-1509
DeLisi LE;
The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia.
Schizophrenia Bulletin.
2008;34(2):312-321
DeLisi LE;
The Katrina disaster and its lessons.
World Psychiatry.
2006;5(1):3-4
DeLisi LE;Bertisch HC;Brown K;Majcher M;Bappal A;Szulc KU;Ardekani BA;
A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.
Harm Reduction Journal.
2006;3(1):17
DeLisi LE;Crow TJ;
Drs. DeLisi and Crow reply.
American Journal of Psychiatry.
2003;160(3):598-599
DeLisi LE;Maurizio A;Yost M;Papparozzi CF;Fulchino C;Katz CL;Altesman J;Biel M;Lee J;Stevens P;
A survey of New Yorkers after the Sept. 11, 2001, terrorist attacks.
American Journal of Psychiatry.
2003;160(4):780-783
DeLisi LE;Shaw SH;Crow TJ;Shields G;Smith AB;Larach VW;Wellman N;Loftus J;Nanthakumar B;Razi K;Stewart J;Comazzi M;Vita A;Heffner T;Sherrington R;
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.
American Journal of Psychiatry.
2002;159(5):803-812
Devanand DP;Marder K;Michaels KS;Sackeim HA;Bell K;Sullivan MA;Cooper TB;Pelton GH;Mayeux R;
A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease.
American Journal of Psychiatry.
1998;155(11):1512-1520
Dias EC;Foxe JJ;Javitt DC;
Changing plans: a high density electrical mapping study of cortical control.
Cerebral Cortex.
2003;13(7):701-715
Dias EC;Segraves MA;
Muscimol-induced inactivation of monkey frontal eye field: effects on visually and memory-guided saccades.
Journal of Neurophysiology.
1999;81(5):2191-2214
Dockstader C;Gaetz W;Cheyne D;Wang F;Castellanos FX;Tannock R;
MEG event-related desynchronization and synchronization deficits during basic somatosensory processing in individuals with ADHD.
Behavioral and Brain Functions.
2008;4:8
Doniger GM;Foxe JJ;Murray MM;Higgins BA;Javitt DC;
Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia.
Archives of General Psychiatry.
2002;59(11):1011-1020
Doniger GM;Silipo G;Rabinowicz EF;Snodgrass JG;Javitt DC;
Impaired sensory processing as a basis for object-recognition deficits in schizophrenia.
American Journal of Psychiatry.
2001;158(11):1818-1826
Ehrlich ME;Sommer J;Canas E;Unterwald EM;
Periadolescent mice show enhanced DeltaFosB upregulation in response to cocaine and amphetamine.
Journal of Neuroscience.
2002;22(21):9155-9159
Feng J;Chi P;Blanpied TA;Xu Y;Magarinos AM;Ferreira A;Takahashi RH;Kao HT;McEwen BS;Ryan TA;Augustine GJ;Greengard P;
Regulation of neurotransmitter release by synapsin III.
Journal of Neuroscience.
2002;22(11):4372-4380
FitzGerald M;Malone KM;Li S;Harrison WM;McBride PA;Endicott J;Cooper T;Mann JJ;
Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
American Journal of Psychiatry.
1997;154(4):556-558
Foxe JJ;Wylie GR;Martinez A;Schroeder CE;Javitt DC;Guilfoyle D;Ritter W;Murray MM;
Auditory-somatosensory multisensory processing in auditory association cortex: an fMRI study.
Journal of Neurophysiology.
2002;88(1):540-543
Francks C;DeLisi LE;Fisher SE;Laval SH;Rue JE;Stein JF;Monaco AP;
Confirmatory evidence for linkage of relative hand skill to 2p12-q11.
American Journal of Human Genetics.
2003;72(2):499-502
Francks C;DeLisi LE;Shaw SH;Fisher SE;Richardson AJ;Stein JF;Monaco AP;
Parent-of-origin effects on handedness and schizophrenia susceptibility on chromosome 2p12-q11.
Human Molecular Genetics.
2003;12(24):3225-3230
Frangos J;Ritter W;Friedman D;
Brain potentials to sexually suggestive whistles show meaning modulates the mismatch negativity.
Neuroreport.
2005;16(12):1313-1317
Frederikse PH;Yun E;Kao HT;Zigler JS;Sun Q;Qazi AS;
Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation.
Molecular Vision.
2004;10:794-804
Fu KM;Johnston TA;Shah AS;Arnold L;Smiley J;Hackett TA;Garraghty PE;Schroeder CE;
Auditory cortical neurons respond to somatosensory stimulation.
Journal of Neuroscience.
2003;23(20):7510-7515
Fu KM;Shah AS;O' Connell MN;McGinnis T;Eckholdt H;Lakatos P;Smiley J;Schroeder CE;
Timing and laminar profile of eye position effects on auditory responses in primate auditory cortex.
Journal of Neurophysiology.
2004;92(6):3522-3531
Galanter M;Dermatis H;Egelko S;De Leon G;
Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic.
Psychiatric Services.
1998;49(4):533-535
Gandy S;Petanceska S;
Authors' reply.
PLoS Medicine.
2005;2(3):e85
George AE;de Leon MJ;Golomb J;Kluger A;Convit A;
Imaging the brain in dementia: expensive and futile?.
American Journal of Neuroradiology.
1997;18(10):1847-1850
Ghoshal N;Smiley JF;DeMaggio AJ;Hoekstra MF;Cochran EJ;Binder LI;Kuret J;
A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease.
American Journal of Pathology.
1999;155(4):1163-1172
Ginsberg SD;Che S;
Combined histochemical staining, RNA amplification, regional, and single cell cDNA analysis within the hippocampus.
Laboratory Investigation.
2004;84(8):952-962
Gitler D;Xu Y;Kao HT;Lin D;Lim S;Feng J;Greengard P;Augustine GJ;
Molecular determinants of synapsin targeting to presynaptic terminals.
Journal of Neuroscience.
2004;24(14):3711-3720
Glazer WM;Conley RR;Citrome L;
Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study.
CNS Spectrums.
2006;11(9 (Suppl 10)):1-13
Gong B;Vitolo OV;Trinchese F;Liu S;Shelanski M;Arancio O;
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
Journal of Clinical Investigation.
2004;114(11):1624-1634
Goodman AB;
Three independent lines of evidence suggest retinoids as causal to schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America.
1998;95(13):7240-7244
Grbovic OM;Mathews PM;Jiang Y;Schmidt SD;Dinakar R;Summers-Terio NB;Ceresa BP;Nixon RA;Cataldo AM;
Rab5-stimulated up-regulation of the endocytic pathway increases intracellular {beta}-cleaved amyloid precursor protein carboxyl-terminal fragment levels and A{beta} production.
Journal of Biological Chemistry.
2003;278(33):31261-31268
Greenberg WM;
Book review: The Antidepressant Survival Program: How to Beat the Side Effects and Enhance the Benefits of Your Medication, by Robert Hedaya.
American Journal of Psychiatry.
2002;159(1):167
Greenberg WM;
Book review: Guidelines for the Systematic Treatment of the Depressed Patient, by Larry Beutler, John Clarkin and Bruce Bongar.
American Journal of Psychiatry.
2002;159(7):1256
Greenberg WM;
Book review: Descriptions and Prescriptions: Values, Mental Disorders and the DSMs, edited by John Z. Sadler [correction in Am J Psychiatry 160:1537, August 2003].
American Journal of Psychiatry.
2003;160(5):1021-1022
Greenberg WM;
The Biopsychosocial Approach: Past, Present, Future [book review].
American Journal of Psychiatry.
2005;162(7):1398
Greenfield JP;Xu HX;Greengard P;Gandy S;Seeger M;
Generation of the amyloid-beta peptide N terminus in Saccharomyces cerevisiae expressing human Alzheimer's amyloid-beta precursor protein.
Journal of Biological Chemistry.
1999;274(48):33843-33846
Grover A;Houlden H;Baker M;Adamson J;Lewis J;Prihar G;Pickering-Brown S;Duff K;Hutton M;
5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.
Journal of Biological Chemistry.
1999;274(21):15134-15143
Guerra CB;Busch R;Doebele RC;Liu W;Sawada T;Kwok WW;Chang MD;Mellins ED;
Novel glycosylation of HLA-DRalpha disrupts antigen presentation without altering endosomal localization.
Journal of Immunology.
1998;160(9):4289-4297
Gugino LD;Chabot RJ;Prichep LS;John ER;Formanek V;Aglio LS;
Quantitative EEG changes associated with loss and return of consciousness in healthy adult volunteers anaesthetized with propofol or sevoflurane.
British Journal of Anaesthesia.
2001;87(3):421-428
Harrison G;Hopper K;Craig T;Laska E;Siegel C;Wanderling J;Dube KC;Ganev K;Giel R;an der HW;Holmberg SK;Janca A;Lee PW;Leon CA;Malhotra S;Marsella AJ;Nakane Y;Sartorius N;Shen Y;Skoda C;Thara R;Tsirkin SJ;Varma VK;Walsh D;Wiersma D;
Recovery from psychotic illness: a 15- and 25-year international follow-up study.
British Journal of Psychiatry.
2001;178:506-517
Hasegawa H;Sanjo N;Chen F;Gu YJ;Shier C;Petit A;Kawarai T;Katayama T;Schmidt S;Mathews P;Ulms G;Fraser PE;St George-Hyslop P;
Both the sequence and length of the C-terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes.
Journal of Biological Chemistry.
2004;279(45):46455-46463
Heijtz RD;Alexeyenko A;Castellanos FX;
Calcyon mRNA expression in the frontal-striatal circuitry and its relationship to vesicular processes and ADHD.
Behavioral and Brain Functions.
2007;3(1):33
Helpern JA;
The missing element [editorial].
American Journal of Neuroradiology.
2001;22(7):1235-1236
Helpern JA;
The promise of high-field-strength MR imaging.
American Journal of Neuroradiology.
2003;24(9):1738-1739
Hemby SE;Ginsberg SD;Brunk B;Arnold SE;Trojanowski JQ;Eberwine JH;
Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex.
Archives of General Psychiatry.
2002;59(7):631-640
Heresco-Levy U;Ermilov M;Shimoni J;Shapira B;Silipo G;Javitt DC;
Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia.
American Journal of Psychiatry.
2002;159(3):480-482
Heresco-Levy U;Javitt DC;Ermilov M;Mordel C;Silipo G;Lichtenstein M;
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia.
Archives of General Psychiatry.
1999;56(1):29-36
Hirasawa M;Ohshima T;Takahashi S;Longenecker G;Honjo Y;Veeranna;Pant HC;Mikoshiba K;Brady RO;Kulkarni AB;
Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects.
Proceedings of the National Academy of Sciences of the United States of America.
2004;101(16):6249-6254
Hopper K;
Returning to the community--again [editorial].
Psychiatric Services.
2002;53(11):1355
Hopper K;
Rethinking social recovery in schizophrenia: what a capabilities approach might offer.
Social Science & Medicine.
2007;65(5):868-879
Hopper K;Barrow SM;
Two genealogies of supported housing and their implications for outcome assessment.
Psychiatric Services.
2003;54(1):50-54
Hoptman MJ;Ardekani BA;Butler PD;Nierenberg J;Javitt DC;Lim KO;
DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis.
Neuroreport.
2004;15(16):2467-2470
Hoptman MJ;Volavka J;Czobor P;Gerig G;Chakos M;Blocher J;Citrome LL;Sheitman B;Lindenmayer JP;Lieberman JA;Bilder RM;
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.
Journal of Neuropsychiatry & Clinical Neurosciences.
2006;18(4):509-515
Hoptman MJ;Volavka J;Weiss EM;Czobor P;Szeszko PR;Gerig G;Chakos M;Blocher J;Citrome LL;Lindenmayer JP;Sheitman B;Lieberman JA;Bilder RM;
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
Psychiatry Research.
2005;140(2):133-145
Hoptman MJ;Yates KF;Patalinjug MB;Wack RC;Convit A;
Clinical prediction of assaultive behavior among male psychiatric patients at a maximum-security forensic facility.
Psychiatric Services.
1999;50(11):1461-1466
Hrabe J;Hrabetova S;Segeth K;
A model of effective diffusion and tortuosity in the extracellular space of the brain.
Biophysical Journal.
2004;87(3):1606-1617
Hrabetova S;Hrabe J;Nicholson C;
Dead-space microdomains hinder extracellular diffusion in rat neocortex during ischemia.
Journal of Neuroscience.
2003;23(23):8351-8359
Hui KS;Saito M;Hui M;
A novel neuron-specific aminopeptidase in rat brain synaptosomes: its identification, purification, and characterization.
Journal of Biological Chemistry.
1998;273(47):31053-31060
Hungund BL;Basavarajappa BS;
Are anandamide and cannabinoid receptors involved in ethanol tolerance? A review of the evidence.
Alcohol and Alcoholism.
2000;35(2):126-133
Ivkovic S;Ehrlich ME;
Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro.
Journal of Neuroscience.
1999;19(13):5409-5419
Javitt DC;
Glutamate involvement in schizophrenia: focus on N-methyl-D-aspartate receptors.
Primary Psychiatry.
2006;13(10):38-46
Javitt DC;Shelley AM;Silipo G;Lieberman JA;
Deficits in auditory and visual context-dependent processing in schizophrenia - Defining the pattern.
Archives of General Psychiatry.
2000;57(12):1131-1137
Javitt DC;Steinschneider M;Schroeder CE;Arezzo JC;
Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America.
1996;93(21):11962-11967
Jones K;Colson PW;Holter MC;Lin S;Valencia E;Susser E;Wyatt RJ;
Cost-effectiveness of critical time intervention to reduce homelessness among persons with mental illness.
Psychiatric Services.
2003;54(6):884-890
Kane JM;Eerdekens M;Lindenmayer JP;Keith SJ;Lesem M;Karcher K;
Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.
American Journal of Psychiatry.
2003;160(6):1125-1132
Kessler RC;Berglund PA;Bruce ML;Koch JR;Laska EM;Leaf PJ;Manderscheid RW;Rosenheck RA;Walters EE;Wang PS;
The prevalence and correlates of untreated serious mental illness.
Health Services Research.
2001;36(6 Pt 1):987-1007
Kim D;Wylie G;Pasternak R;Butler PD;Javitt DC;
Magnocellular contributions to impaired motion processing in schizophrenia.
Schizophrenia Research.
2006;82(1):1-8
King SR;Ginsberg SD;Ishii T;Smith RG;Parker KL;Lamb DJ;
The steroidogenic acute regulatory (StAR) protein Is expressed in steroidogenic cells of the day-old (P1) brain.
Endocrinology.
2004;145(10):4775-4780
King SR;Manna PR;Ishii T;Syapin PJ;Ginsberg SD;Wilson K;Walsh LP;Parker KL;Stocco DM;Smith RG;Lamb DJ;
An essential component in steroid synthesis, the steroidogenic acute regulatory protein, is expressed in discrete regions of the brain.
Journal of Neuroscience.
2002;22(24):10613-10620
Klein RL;Lin WL;Dickson DW;Lewis J;Hutton M;Duff K;Meyer EM;King MA;
Rapid neurofibrillary tangle formation after localized gene transfer of mutated tau.
American Journal of Pathology.
2004;164(1):347-353
Komano H;Seeger M;Gandy S;Wang GT;Krafft GA;Fuller RS;
Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast.
Journal of Biological Chemistry.
1998;273(48):31648-31651
Kowa H;Sakakura T;Matsuura Y;Wakabayashi T;Mann DM;Duff K;Tsuji S;Hashimoto T;Iwatsubo T;
Mostly separate distributions of CLAC- versus Abeta40- or thioflavin S-reactivities in senile plaques reveal two distinct subpopulations of beta-amyloid deposits.
American Journal of Pathology.
2004;165(1):273-281
Krakowski M;
Violent behavior: choosing antipsychotics and other agents.
Current Psychiatry.
2007;6(4):63-70
Krakowski M;Czobor P;
Gender differences in violent behaviors: relationship to clinical symptoms and psychosocial factors.
American Journal of Psychiatry.
2004;161(3):459-465
Krakowski MI;Czobor P;
Psychosocial risk factors associated with suicide attempts and violence among psychiatric inpatients.
Psychiatric Services.
2004;55(12):1414-1419
Krakowski MI;Czobor P;Citrome L;Bark N;Cooper TB;
Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Archives of General Psychiatry.
2006;63(6):622-629
Kunz M;Yates KF;Czobor P;Rabinowitz S;Lindenmayer JP;Volavka J;
Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral program.
Psychiatric Services.
2004;55(6):654-659
Kurylo DD;Pasternak R;Silipo G;Javitt DC;Butler PD;
Perceptual organization by proximity and similarity in schizophrenia.
Schizophrenia Research.
2007;95(1-3):205-214
Lachman HM;Nolan KA;Mohr P;Saito T;Volavka J;
Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder.
American Journal of Psychiatry.
1998;155(6):835-837
Lacombe P;Mathews PM;Schmidt SD;Breidert T;Heneka MT;Landreth GE;Feinstein DL;Galea E;
Effect of anti-inflammatory agents on transforming growth factor beta over-expressing mouse brains: a model revised.
Journal of Neuroinflammation.
2004;1:11
Lakatos P;Shah AS;Knuth KH;Ulbert I;Karmos G;Schroeder CE;
An oscillatory hierarchy controlling neuronal excitability and stimulus processing in the auditory cortex.
Journal of Neurophysiology.
2005;94(3):1904-1911
Laska EM;
The use of capture-recapture methods in public health [editorial].
Bulletin of the World Health Organization.
2002;80(11):845
Laudon H;Karlstrom H;Mathews PM;Farmery MR;Gandy SE;Lundkvist J;Lendahl U;Naslund J;
Functional domains in presenilin 1: the Tyr-288 residue controls gamma -secretase activity and endoproteolysis.
Journal of Biological Chemistry.
2004;279(23):23925-23932
Leadbetter RA;Shutty MS;Elkashef AM;Kirch DG;Spraggins T;Cail WS;Wu H;Bilder RM;Lieberman JA;Wyatt RJ;
MRI changes during water loading in patients with polydipsia and intermittent hyponatremia.
American Journal of Psychiatry.
1999;156(6):958-960
Leavitt VM;Molholm S;Ritter W;Shpaner M;Foxe JJ;
Auditory processing in schizophrenia during the middle latency period (10-50 ms): high-density electrical mapping and source analysis reveal subcortical antecedents to early cortical deficits.
Journal of Psychiatry & Neuroscience.
2007;32(5):339-353
Lebon V;Petersen KF;Cline GW;Shen J;Mason GF;Dufour S;Behar KL;Shulman GI;Rothman DL;
Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism.
Journal of Neuroscience.
2002;22(5):1523-1531
Lencz T;Bilder RM;Turkel E;Goldman RS;Robinson D;Kane JM;Lieberman JA;
Impairments in perceptual competency and maintenance on a visual delayed match-to-sample test in first-episode schizophrenia.
Archives of General Psychiatry.
2003;60(3):238-243
Levine IS;Moss S;
Mental health resources on the web for families: a quick reference guide.
.
2002;revised 4/02:
Levine J;Jaffe A;
Antipsychotic medication utilization in a state mental hospital system, 1994-2000.
.
2004;:199-208
Lewis CM;Levinson DF;Wise LH;DeLisi LE;Straub RE;Hovatta I;Williams NM;Schwab SG;Pulver AE;Faraone SV;Brzustowicz LM;Kaufmann CA;Garver DL;Gurling HM;Lindholm E;Coon H;Moises HW;Byerley W;Shaw SH;Mesen A;Sherrington R;O'Neill FA;Walsh D;Kendler KS;Ekelund J;Paunio T;Lonnqvist J;Peltonen L;O'Donovan MC;Owen MJ;Wildenauer DB;Maier W;Nestadt G;Blouin JL;Antonarakis SE;Mowry BJ;Silverman JM;Crowe RR;Cloninger CR;Tsuang MT;Malaspina D;Harkavy-Friedman JM;Svrakic DM;Bassett AS;Holcomb J;Kalsi G;McQuillin A;Brynjolfson J;Sigmundsson T;Petursson H;Jazin E;Zoega T;Helgason T;
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.
American Journal of Human Genetics.
2003;73(1):34-48
Li X;Branch CA;Bertisch HC;Brown K;Szulc KU;Ardekani BA;DeLisi LE;
An fMRI study of language processing in people at high genetic risk for schizophrenia.
Schizophrenia Research.
2007;91(1-3):62-72
Lim KO;Adalsteinsson E;Spielman D;Sullivan EV;Rosenbloom MJ;Pfefferbaum A;
Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Archives of General Psychiatry.
1998;55(4):346-352
Lim KO;Ardekani BA;Nierenberg J;Butler PD;Javitt DC;Hoptman MJ;
Voxelwise correlational analyses of white matter integrity in multiple cognitive domains in schizophrenia.
American Journal of Psychiatry.
2006;163(11):2008-2010
Lim KO;Hedehus M;Moseley M;deCrespigny A;Sullivan EV;Pfefferbaum A;
Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.
Archives of General Psychiatry.
1999;56(4):367-374
Lindenmayer JP;Czobor P;Volavka J;Citrome L;Sheitman B;Mcevoy JP;Cooper TB;Chakos M;Lieberman JA;
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
American Journal of Psychiatry.
2003;160(2):290-296
Lindenmayer JP;Patel R;
Olanzapine-induced ketoacidosis with diabetes mellitus.
American Journal of Psychiatry.
1999;156(9):1471
Lipton FR;Siegel C;Hannigan A;Samuels J;Baker S;
Tenure in supportive housing for homeless persons with severe mental illness.
Psychiatric Services.
2000;51(4):479-486
Lipton ML;Fu KM;Branch CA;Schroeder CE;
Ipsilateral hand input to area 3b revealed by converging hemodynamic and electrophysiological analyses in macaque monkeys.
Journal of Neuroscience.
2006;26(1):180-185
Lusskin SI;Cancro R;Chuang L;Jacobson J;
Prolactin elevation with ziprasidone [letter].
American Journal of Psychiatry.
2004;161(10):1925
|